FDA Drafts Guidance for Inhaled Nicotine-Containing Drugs

The FDA unveiled new draft guidance on nonclinical testing of orally-inhaled drug products that contain nicotine — and Commissioner Scott Gottlieb said the agency plans to release follow-up guidelines later this year on potentially clinically relevant outcomes.
Source: International Pharmaceutical Regulatory Monitor